TERAZOSIN Safety Questions, TERAZOSIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TERAZOSIN. Our extensive database of TERAZOSIN adverse events and TERAZOSIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TERAZOSIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



TERAZOSIN Safety Reports

Total TERAZOSIN reports: 116.
TERAZOSIN FDA safety alerts: No.
   Reported hospitalizations: 63.
Take TERAZOSIN Side Effects Survey or Share Your TERAZOSIN Story. Read More Here.

Showing 1-75 of 116 Next >

Health Professional from UNITED STATES reported TERAZOSIN problem on Nov 16, 2006. Male patient, 83 years of age, weighting 144.0 lb, was diagnosed with prostatic disorder and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness. TERAZOSIN dosage: 2 MG QHS BY MOUTH. During the same period patient was treated with FLUTICASONE PROP, IPRATROPIUM BROMIDE, FUROSEMIDE, LANOXIN, SPIRONOLACTONE, ALBUTEROL, CALCIUM 250MG, FLUTICASONE PROP. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Nov 16, 2006. Male patient, 83 years of age, weighting 135.8 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension. TERAZOSIN dosage: unknown. During the same period patient was treated with SYNTHROID, NITROFURANTOIN MACROCRYSTALLINE, POLYSTYENE SULF, METOCLOPRAMIDE, ARTIFICIAL TEARS POLYVINYL ALCOHOL, ACETAMINOPHEN, OMEPRAZOLE, PHOSHORUS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TERAZOSIN problem on Nov 06, 2006. Female patient, 54 years of age, was diagnosed with hypertension and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, blood pressure systolic increased, iatrogenic injury, procedural complication, retinal haemorrhage, retinal scar, tachycardia, vision blurred. TERAZOSIN dosage: 1 MG; HS; PO. During the same period patient was treated with NORVASC, GUANFACINE, AVAPRO, INSULIN, SYNTHROID, MINOXIDIL, METOPROLOL SUCCINATE. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Dec 01, 2006. Male patient, 70 years of age, weighting 178.8 lb, was diagnosed with benign prostatic hyperplasia, hypertension, cardiac failure congestive and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: asthenia, dizziness, hypotension, nausea, renal failure acute. TERAZOSIN dosage: 10 MG PO DAILY AT BEDTIME. During the same period patient was treated with LISINOPRIL, FUROSEMIDE, CARVEDILOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TERAZOSIN problem on Dec 06, 2006. Male patient, 75 years of age, weighting 147.9 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension. TERAZOSIN dosage: unknown. Patient recovered.

TERAZOSIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Male patient, 65 years of age, weighting 134.0 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: syncope. TERAZOSIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TERAZOSIN problem on Dec 06, 2006. Male patient, 76 years of age, weighting 145.1 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: orthostatic hypotension. TERAZOSIN dosage: unknown. Patient recovered.

TERAZOSIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Male patient, 77 years of age, weighting 182.5 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension. TERAZOSIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TERAZOSIN problem on Dec 06, 2006. Male patient, 80 years of age, weighting 164.7 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness. TERAZOSIN dosage: unknown. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Dec 06, 2006. Male patient, 84 years of age, weighting 177.0 lb, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, fall, head injury, subdural haematoma, syncope. TERAZOSIN dosage: 1MG PO AT BEDTIME. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TERAZOSIN problem on Dec 08, 2006. Male patient, weighting 184.0 lb, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: agitation, arthralgia, dizziness, dry eye, nervousness. TERAZOSIN dosage: 5MG ONCE EVERY DAY P.O.. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Dec 12, 2006. Male patient, 74 years of age, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, syncope. TERAZOSIN dosage: 2MG QD PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TERAZOSIN problem on Dec 13, 2006. Male patient, weighting 162.1 lb, was diagnosed with prostate examination abnormal and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, prostate cancer. TERAZOSIN dosage: unknown. During the same period patient was treated with ALFUZOSIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on July 11, 2007. Male patient, 86 years of age, weighting 159.0 lb, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension. TERAZOSIN dosage: 2MG, 2MG HS, ORAL. During the same period patient was treated with LISINOPRIL AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on July 11, 2007. Male patient, 84 years of age, weighting 117.3 lb, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: syncope. TERAZOSIN dosage: 5MG, 5MG HS, ORAL. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on July 11, 2007. Male patient, 75 years of age, weighting 191.8 lb, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, orthostatic hypotension. TERAZOSIN dosage: 5MG,5MG HS, ORAL. During the same period patient was treated with METOPROLOL TARTRATE, LOSARTAN POTASSIUM, FUROSEMIDE, FELODIPINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on July 13, 2007. Male patient, 85 years of age, weighting 173.1 lb, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, hypotension. TERAZOSIN dosage: 5MG HS PO. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Health Professional from UNITED STATES on July 12, 2007. Male patient, weighting 174.2 lb, was diagnosed with hypertension, coronary artery disease and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: constipation, small bowel angioedema. TERAZOSIN dosage: unknown. During the same period patient was treated with LISINOPRIL, ACETYLSALICYLIC ACID SRT, ACETYLSALICYLIC ACID SRT, VITAMIN CAP, VITAMIN CAP. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported TERAZOSIN problem on July 12, 2007. Male patient, weighting 174.2 lb, was diagnosed with hypertension, coronary artery disease and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: angioedema, constipation. TERAZOSIN dosage: unknown. During the same period patient was treated with LISINOPRIL, ACETYLSALICYLIC ACID SRT, ACETYLSALICYLIC ACID SRT, VITAMIN CAP, VITAMIN CAP. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Male patient, 68 years of age, weighting 168.4 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension. TERAZOSIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on July 25, 2007. Male patient, 73 years of age, weighting 202.6 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, orthostatic hypotension, syncope. TERAZOSIN dosage: unknown. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on July 25, 2007. Male patient, 73 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension. TERAZOSIN dosage: 5MG HS PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TERAZOSIN problem on July 25, 2007. Male patient, 73 years of age, weighting 214.1 lb, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: orthostatic hypotension. TERAZOSIN dosage: unknown. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on July 30, 2007. Male patient, 57 years of age, was diagnosed with dysuria and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension, syncope. TERAZOSIN dosage: 4MG EVERY DAY PO. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Aug 06, 2007. Male patient, 63 years of age, was diagnosed with hypertension and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, orthostatic hypotension. TERAZOSIN dosage: 5MG HS PO. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Aug 13, 2007. Male patient, 77 years of age, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness. TERAZOSIN dosage: 5MG HS PO. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Aug 13, 2007. Male patient, 71 years of age, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness. TERAZOSIN dosage: 2MG HS PO. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Aug 15, 2007. Male patient, 62 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, hypotension. TERAZOSIN dosage: 5MG BID PO. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Aug 21, 2007. Male patient, 62 years of age, was diagnosed with hypertension and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: hypotension, syncope. TERAZOSIN dosage: 5MG HS PO. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Aug 30, 2007. Male patient, 64 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, syncope. TERAZOSIN dosage: 10MG HS PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from INDIA reported TERAZOSIN problem on Aug 27, 2007. Male patient, 72 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: floppy iris syndrome. TERAZOSIN dosage: unknown. Patient recovered.

TERAZOSIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Male patient, 62 years of age, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: renal failure, sinus bradycardia. TERAZOSIN dosage: unknown. During the same period patient was treated with VERAPAMIL, ATENOLOL, CLONIDINE, IRBESARTAN, FUROSEMIDE, METOLAZONE, INSULIN, NAPROXEN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Sept 06, 2007. Male patient, 86 years of age, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, syncope. TERAZOSIN dosage: 2 MG HS PO. Patient recovered.

TERAZOSIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2007. Female patient was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, discomfort, insomnia. TERAZOSIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Sept 13, 2007. Male patient, 67 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: syncope. TERAZOSIN dosage: 10MG HS PO. Patient was hospitalized. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Sept 17, 2007. Male patient, 62 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, hypotension, syncope. TERAZOSIN dosage: 4MG EVERY DAY PO. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Sept 18, 2007. Male patient, 68 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness. TERAZOSIN dosage: 2MG EVERY DAY PO. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2007. Male patient, 88 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness. TERAZOSIN dosage: 7MG HS PO. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Sept 20, 2007. Male patient, 85 years of age, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, sedation. TERAZOSIN dosage: 2MG HS PO. Patient recovered.

TERAZOSIN problem was reported by a Pharmacist from UNITED STATES on Sept 20, 2007. Male patient, 78 years of age, was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, muscle spasms. TERAZOSIN dosage: 5MG HS PO. Patient recovered.

Pharmacist from UNITED STATES reported TERAZOSIN problem on Sept 20, 2007. Male patient, 75 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TERAZOSIN. After drug was administered, patient experienced the following problems/side effects: dizziness, orthostatic hypotension. TERAZOSIN dosage: 5MG EVERY DAY PO. Patient recovered.

Showing 1-75 of 116 Next >

Ask Our Patient Community about TERAZOSIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase (prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ramelteon)

back to top

S
Sacrosidase
Salmeterol xinafoate
Sanctura (trospium)
Seconal (secobarbital)
Secobarbital
Selzentry
Sensipar (cinacalcet)
Serevent Diskus (salmeterol xinafoate)
Seroquel (quetiapine)
Sertaconazole
SertralineThis drug has as active FDA Safety Alert
SerzoneThis drug has as active FDA Safety Alert (nefazodone)
Sevelamer
Sildenafil citrate
Sirolimus
Simvastatin
Sitagliptin phosphate
SkelidThis drug has as active FDA Safety Alert (tiludronate)
Sodium ferric gluconate complex
Sodium phosphatesThis drug has as active FDA Safety Alert
Solage (mequinol; tretinoin)
Soliris (eculizumab)
Solifenacin succinate
Somavert (pegvisomant)
Sonata (zaleplon)
Sorafenib
SotretThis drug has as active FDA Safety Alert (isotretinoin)
Spectracef (cefditoren pivoxil)
Spiriva (tiotropium bromide)
Sprycel (dasatinib)
Starlix (nateglinide)
Stimate Nasal SprayThis drug has as active FDA Safety Alert(desmopressin)
StratteraThis drug has as active FDA Safety Alert (atomoxetine)
Sucraid (sacrosidase)
SumatriptanThis drug has as active FDA Safety Alert
Sunitinib
Sustiva (efavirenz)
Sutent (sunitinib)
SymbyaxThis drug has as active FDA Safety Alert (olanzapine/fluoxetine)
Symlin (pramlintide acetate)
Synercid (quinupristin; dalfopristin)

back to top

T
Tacrolimus
Tadalafil
Tamiflu (oseltamivir phosphate)
Tasmar (tolcapone)
Targretin (bexarotene)
Technetium Tc 99m apcitide
Technetium Tc 99m depreotide
Tegaserod maleate
TegretolThis drug has as active FDA Safety Alert (carbamazepine)
Telbivudine
Telithromycin
Telmisartan
Temazepam
Temodar (temozolomide)
Temozolomide
TequinThis drug has as active FDA Safety Alert (gatifloxacin)
Thalidomide
Thalomid (thalidomide)
Thyrogen (thyrotropin alfa)
Thyrotropin alfa
TiagabineThis drug has as active FDA Safety Alert
Tigecycline
Tikosyn (dofetilide)
TiludronateThis drug has as active FDA Safety Alert
Tindamax (tinidazole)
Tinidazole
Tinzaparin
Tiotropium bromide
Tipranavir
Tirofiban
Tobramycin
Tolcapone
Tolterodine tartrate
Topical Anesthetics
TopiramateThis drug has as active FDA Safety Alert
TopamaxThis drug has as active FDA Safety Alert (Topiramate)
TrandolaprilThis drug has as active FDA Safety Alert
Trasylol (aprotinin)
Travatan (travoprost)
Travoprost
Triazolam
TrileptalThis drug has as active FDA Safety Alert (oxcarbazepine)
Trisenox (arsenic trioxide)
Tretinoin
Trospium
Tygacil (tigecycline)
Trypan Blue Ophthalmic Solution